PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough trial aims to extend lives of pancreatic cancer patients
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called telisotuzumab adizutecan to standard chemotherapy works better for people with advanced pancreatic cancer that has spread. About 900 patients worldwide will receive either the new combination or standard treatment a…
Matched conditions: PDAC
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug targets common Cancer-Causing mutation in major trial
Disease control Not yet recruitingThis study is testing a new drug called GFH276 in adults with advanced cancers that have a specific genetic change called a RAS mutation. The main goals are to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, lung, and colorectal cancer. It is an…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC